Autoantibody signatures in SARS CoV 2 infected and vaccinated individuals

What kind of autoantibody responses can we see in COVID-19? We conducted a small study in which we analyzed sera from both COVID-19 patients and vaccinated individuals to identify and profile cross-reactivity against human autoantigens.  

In this webinar held on November 11th 2021, Dr. Kirsten Heiss takes us through the study and describes peptide microarrays can be applied for the analysis of antibody cross-reactivity in the context of infection and autoimmunity.